Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fearon

Showing results (71-80 of 239) with videos related to

Pageof 24
Sort By:
Science (New York, N.Y.)|January 24, 2009
Secondary replicative function of CD8+ T cells that had developed an effector phenotypeOliver Bannard, Matthew Kraman, Douglas T Fearon
La Nouvelle Presse Medicale|June 9, 1979
[Alternative complement pathway (author's transl)]M Kazatchkine, U Nydegger, D T Fearon
Current Opinion in Immunology|June 1, 1997
Co-receptors of B lymphocytesL O'Rourke, R Tooze, D T Fearon
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2024
Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancerJiayun Li, Philip Moresco, Douglas T Fearon
Clinical and Experimental Immunology|April 1, 1984
Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysisJ Lee, R M Hakim, D T Fearon
Science (New York, N.Y.)|October 4, 1991
Suppression of the immune response by a soluble complement receptor of B lymphocytesT Hebell, J M Ahearn, D T Fearon
Science (New York, N.Y.)|July 14, 2001
Arrested differentiation, the self-renewing memory lymphocyte, and vaccinationD T Fearon, P Manders, S D Wagner
Health Physics|April 1, 1975
Energy spectra and fractional absorbed dose distributions in LET for 14-MeV neutronsT Fearon, H D Maillie, W A Kremer
Current Opinion in Immunology|February 1, 1994
Innate immunity: 50 ways to kill a microbeE Brown, J P Atkinson, D T Fearon
The Journal of Experimental Medicine|August 1, 1974
Properdin factor D. II. Activation to D by properdinD T Fearon, K F Austen, S Ruddy
Pageof 24

Showing results (71-80 of 239) with videos related to

Sort By:
Pageof 24
Science (New York, N.Y.)|January 24, 2009
Secondary replicative function of CD8+ T cells that had developed an effector phenotypeOliver Bannard, Matthew Kraman, Douglas T Fearon
La Nouvelle Presse Medicale|June 9, 1979
[Alternative complement pathway (author's transl)]M Kazatchkine, U Nydegger, D T Fearon
Current Opinion in Immunology|June 1, 1997
Co-receptors of B lymphocytesL O'Rourke, R Tooze, D T Fearon
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2024
Intratumoral NKT cell accumulation promotes antitumor immunity in pancreatic cancerJiayun Li, Philip Moresco, Douglas T Fearon
Clinical and Experimental Immunology|April 1, 1984
Increased expression of the C3b receptor by neutrophils and complement activation during haemodialysisJ Lee, R M Hakim, D T Fearon
Science (New York, N.Y.)|October 4, 1991
Suppression of the immune response by a soluble complement receptor of B lymphocytesT Hebell, J M Ahearn, D T Fearon
Science (New York, N.Y.)|July 14, 2001
Arrested differentiation, the self-renewing memory lymphocyte, and vaccinationD T Fearon, P Manders, S D Wagner
Health Physics|April 1, 1975
Energy spectra and fractional absorbed dose distributions in LET for 14-MeV neutronsT Fearon, H D Maillie, W A Kremer
Current Opinion in Immunology|February 1, 1994
Innate immunity: 50 ways to kill a microbeE Brown, J P Atkinson, D T Fearon
The Journal of Experimental Medicine|August 1, 1974
Properdin factor D. II. Activation to D by properdinD T Fearon, K F Austen, S Ruddy
Pageof 24